Home » Topics » Regulatory

Regulatory
RSS

DuPont seeks FDA approval for new formulation of Sustiva

April 6, 2001

Second-line antihypertensive combination therapy launched in U.S.

April 6, 2001

Additional study needed to support transdermal methylphenidate NDA

April 6, 2001

FDA approves Celltech's once-daily ADHD treatment

April 5, 2001

Sepracor submits sNDA to FDA for pediatric use of Xopenex

April 4, 2001

Valcyte approved by FDA for AIDS-related CMV

April 3, 2001

Health Canada approves Pantoloc for treatment of heartburn

April 3, 2001

FDA grants priority review status for Entocort modified-release capsules

April 2, 2001

European approval granted for Sanofi-Synthelabo's Fasturtec

March 30, 2001

PEG-Intron/Rebetol combination for hepatitis C treatment approved in E.U.

March 30, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...
Research grants support early clinical trials of ALS treatments
BioWorld Science
The ALS Association has announced the recipients of its 2025 Hoffman ALS Clinical Trial Awards. These research grants, worth up to $1 million each, support...